BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 34006241)

  • 1. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
    Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
    BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
    Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
    Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
    JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
    Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
    BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
    Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
    Cai JS; Chen HY; Lu YF; Yu RS
    Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
    [No Abstract]   [Full Text] [Related]  

  • 7. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study.
    Li J; Huang L; Liao C; Liu G; Tian Y; Chen S
    BMC Cancer; 2023 Jun; 23(1):529. PubMed ID: 37296397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram prognostic model for patients with neuroendocrine tumors of the thymus.
    Tang JY; Gao HJ; Shi GD; Guo XK; Yu WQ; Wang HF; Wei YC
    Thorac Cancer; 2020 Sep; 11(9):2457-2464. PubMed ID: 32656987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
    Tong Z; Liu L; Zheng Y; Jiang W; Zhao P; Fang W; Wang W
    World J Surg Oncol; 2017 May; 15(1):108. PubMed ID: 28558772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
    Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
    [No Abstract]   [Full Text] [Related]  

  • 14. Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.
    Fan Z; Chi C; Tong Y; Huang Z; Song Y; You S
    Technol Cancer Res Treat; 2022; 21():15330338211066240. PubMed ID: 35006028
    [No Abstract]   [Full Text] [Related]  

  • 15. Nomogram for individually predicting overall survival in rectal neuroendocrine tumours.
    Feng X; Wei G; Wang W; Zhang Y; Zeng Y; Chen M; Chen Y; Chen J; Zhou Z; Li Y
    BMC Cancer; 2020 Sep; 20(1):865. PubMed ID: 32907602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
    Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
    Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
    BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
    He Y; Liu H; Wang S; Chen Y
    PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
    Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
    Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.